Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Aterian Inc (ATER) vs Northrop Grumman Corporation (NOC) Price & Performance

Aterian IncTrade
Northrop Grumman CorporationTrade

Price performance (Past 24H)

Key statistics

Aterian Inc vs Northrop Grumman Corporation — how do they compare? Aterian Inc trades at $0.49 (market cap $5.32M), while Northrop Grumman Corporation trades at $574.99 (market cap $81.78B). The key difference: Northrop Grumman Corporation is far larger — about 15372.2× Aterian Inc's market cap, and Northrop Grumman Corporation pays a 1.63% dividend while Aterian Inc pays none. Which is the better fit depends on your goals.

ATERNOC
Market Cap
$5.32M$81.78B
Sector
Consumer CyclicalIndustrials
52-Week High
$1.39$768.02
52-Week Low
$0.36$496.02
Enterprise Value
$5.90M$95.77B
Dividend Yield
1.63%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Aterian Inc

Aterian (ATER) trades at $0.489, up 1.88% with a bearish technical signal despite recent earnings beats. The company faces significant financial challenges with negative net income margins (-30.78%) and declining revenue from $221M in 2022 to $69M in 2025. Recent news highlights a pending asset sale that could return $0.85-$1.14 per share to stockholders, creating near-term catalyst potential. Cash flow remains negative at -$13.14M for 2025, though the balance sheet shows $18M cash against $19.3M current liabilities.

The outlook hinges on the proposed asset sale delivering shareholder value, with technical indicators suggesting caution. Investment opportunity exists if the sale completes favorably, but risks include ongoing operational losses, declining revenue, and negative cash flow. Analyst sentiment is split 50/50 buy/hold, reflecting uncertainty about the company's turnaround prospects beyond the immediate transaction.

Northrop Grumman Corporation

Northrop Grumman (NOC) trades at $577.89, up 1.1% today, with a bullish technical signal from moving averages and a record $105 billion backlog supporting fundamentals. Recent Q2 2026 earnings beat expectations, with sales growth of 5% and raised full-year guidance (Seeking Alpha, 2026-07-23). Valuation ratios like P/E of 18.3 and ROE of 26.96% reflect strong profitability, though RSI levels indicate overbought conditions.

The outlook is positive due to defense spending tailwinds and strategic contracts, but risks include margin pressure from specific programs and geopolitical volatility. Analysts maintain a buy consensus with a $598.57 price target, suggesting modest upside from current levels.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Aterian Inc

Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products, and consumer electronics. It has various owned and operated brands include Vremi, Healing Solutions, Xtava, TRUWEO, Spiralize, Pohl+Schmitt, and RIF6. The company generates revenue through the online sales of various consumer products that are sold online.

Read more on ATER

About Northrop Grumman Corporation

Northrop Grumman is a defense contractor that is diversified across short-cycle and long-cycle businesses. The firm's segments include aeronautics, mission systems, defense services, and space systems. The company's aerospace segment creates the fuselage for the massive F-35 program and produces various piloted and autonomous flight systems. Mission systems creates a variety of sensors and processors for defense hardware. The defense systems segment is a long-range missile manufacturer. Finally, the company's space systems segment produces various space structures, sensors, and satellites.

Read more on NOC